P045 The impact of lumacaftor/ivacaftor and tezacaftor/ivacaftor on health outcomes in the setting of severe lung disease due to cystic fibrosis

G. Alrehaili, M. Gravel, X. Ma, J. Sykes,A. Coriati,S. Stanojevic, L. Bilodeau, A.L. Stephenson

Journal of Cystic Fibrosis(2022)

引用 0|浏览1
暂无评分
关键词
cystic fibrosis,severe lung disease,lumacaftor/ivacaftor,lung disease
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要